Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30038889HIVENSG00000140464.20protein_codingPMLNoYes5371P29590
TVIS30038890HIVENSG00000140464.20protein_codingPMLNoYes5371P29590
TVIS30017653HIVENSG00000140464.20protein_codingPMLNoYes5371P29590
TVIS20024524HPVENSG00000140464.20protein_codingPMLNoYes5371P29590
TVIS20052456HPVENSG00000140464.20protein_codingPMLNoYes5371P29590
TVIS20024526HPVENSG00000140464.20protein_codingPMLNoYes5371P29590
TVIS20024522HPVENSG00000140464.20protein_codingPMLNoYes5371P29590
TVIS44047329HTLV-1ENSG00000140464.20protein_codingPMLNoYes5371P29590
TCGA Plot Options
Drug Information
GenePML
DrugBank IDDB01169
Drug NameArsenic trioxide
Target IDBE0005808
UniProt IDP29590
Regulation Type
PubMed IDs20378816
CitationsZhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB, Liang WX, Song AX, Lallemand-Breitenbach V, Jeanne M, Zhang QY, Yang HY, Huang QH, Zhou GB, Tong JH, Zhang Y, Wu JH, Hu HY, de The H, Chen SJ, Chen Z: Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science. 2010 Apr 9;328(5975):240-3. doi: 10.1126/science.1183424.
GroupsApproved; Investigational
Direct ClassificationMetalloid oxides
SMILESO=[As]O[As]=O
Pathways
PharmGKBPA448486
ChEMBLCHEMBL1200978